•  33
    Freedom and moral enhancement
    Journal of Medical Ethics 40 (4): 215-216. 2014.
    This issue of Journal of Medical Ethics includes a pair of papers debating the implications of moral bioenhancement for human freedom–and, especially, the question of whether moral enhancement should potentially be compulsory. In earlier writings Ingmar Persson and Julian Savulescu argue that compulsory moral bioenhancement may be necessary to prevent against catastrophic harms that might result from immoral behaviour.1 In “Voluntary moral enhancement and the survival-at-any-cost bias” Vojin Rak…Read more
  •  15
    Specifying the duty to treat
    with Yen-Chang Chen
    American Journal of Bioethics 8 (8). 2008.
    No abstract
  •  9
    Eugenic abortion, moral uncertainty, and social consequences
    Monash Bioethics Review 20 (2): 26-42. 2001.
    The proliferation of prenatal genetic testing likely to follow from advances in genetic science invites reconsideration of the moral status of abortion. In this article I examine arguments surrounding the moral status of the fetus. I conclude that secular philosophy should ultimately admit that the moral status of the fetus is uncertain, and that this uncertainty itself makes abortion morally problematic. While this does not imply that abortion is always morally wrong or that it should be legall…Read more
  •  5
    From the Guest Editors
    Developing World Bioethics 4 (1). 2004.
  •  16
    Central to the argument of ‘Biodefense and the Production of Knowledge: Rethinking the Problem’ are claims that the vast majority of ethical debate about biodefense research to date has focused on the dual use problem, and the focus of ethical discussion of dual-use research has been on the need to strike ‘a proper balance of only two dominant values: biosecurity and “open science”’ —the idea being that ‘under current conditions other values can and ought to be ignored because the stakes are so …Read more
  •  12
    Ethics, health policy, and Zika: From emergency to global epidemic?
    with Euzebiusz Jamrozik
    Journal of Medical Ethics 44 (5): 343-348. 2018.
    Zika virus was recognised in 2016 as an important vector-borne cause of congenital malformations and Guillain-Barré syndrome, during a major epidemic in Latin America, centred in Northeastern Brazil. The WHO and Pan American Health Organisation, with partner agencies, initiated a coordinated global response including public health intervention and urgent scientific research, as well as ethical analysis as a vital element of policy design. In this paper, we summarise the major ethical issues rais…Read more
  •  6
    Conflicting clinical duties
    Journal of Medical Ethics 41 (3): 213-214. 2015.
  • The dual-use dilemma-Reply
    Hastings Center Report 37 (5): 6-7. 2007.
  •  7
  •  18
    A relational approach to saviour siblings?
    Journal of Medical Ethics 41 (12): 924-925. 2015.
  •  29
    In this article, we raise ethical concerns about the potential misuse of open-source biology : biological research and development that progresses through an organisational model of radical openness, deskilling, and innovation. We compare this organisational structure to that of the open-source software model, and detail salient ethical implications of this model. We demonstrate that OSB, in virtue of its commitment to openness, may be resistant to governance attempts
  •  12
    Just liability and reciprocity reasons for treating wounded soldiers
    American Journal of Bioethics 8 (2). 2008.
    This Article does not have an abstract
  •  18
    Ethics, economics, and aids in Africa
    Developing World Bioethics 4 (1). 2004.
    AIDS in the Twenty‐First Century: Disease and Globalization, by Tony Barnett and Alan Whiteside. New York: Palgrave Macmillan. 2002. 416 pp. US$19.95 The Moral Economy of AIDS in South Africa, by Nicoli Nattrass. Cambridge, UK: Cambridge University Press. 2004. 222 pp. US$30.00
  •  11
    Democratic Defense Spending in an Age of Bioterrorism
    American Journal of Bioethics 5 (4): 49-50. 2005.
    No abstract
  •  84
    An Argument against Arguments for Enhancement
    Studies in Ethics, Law, and Technology 1 (1). 2007.
  •  44
    Ethics and drug resistance
    Bioethics 21 (4). 2007.
  •  58
    : Some scientific research should not be published. The risks to national security and public health override the social benefits of disseminating scientific results openly. Unfortunately, scientists themselves are not in a position to know which studies to withhold from public view, as the National Research Council has proposed. Yet neither can government alone be trusted to balance the competing interests at stake
  •  128
    Mass vaccination has been a successful public health strategy for many contagious diseases. The immunity of the vaccinated also protects others who cannot be safely or effectively vaccinated—including infants and the immunosuppressed. When vaccination rates fall, diseases like measles can rapidly resurge in a population. Those who cannot be vaccinated for medical reasons are at the highest risk of severe disease and death. They thus may bear the burden of others' freedom to opt out of vaccinatio…Read more
  •  115
    Moderate eugenics and human enhancement
    Medicine, Health Care and Philosophy 17 (1): 3-12. 2014.
    Though the reputation of eugenics has been tarnished by history, eugenics per se is not necessarily a bad thing. Many advocate a liberal new eugenics—where individuals are free to choose whether or not to employ genetic technologies for reproductive purposes. Though genetic interventions aimed at the prevention of severe genetic disorders may be morally and socially acceptable, reproductive liberty in the context of enhancement may conflict with equality. Enhancement could also have adverse effe…Read more
  •  20
    Ethics, tuberculosis and globalization
    Public Health Ethics 1 (1): 10-20. 2008.
    CAPPE LPO Box 8260 ANU Canberra ACT 2601 Australia Tel: +61 (0)2 6125 4355, Fax: +61 (0)2 6125 6579; Email: michael.selgelid{at}anu.edu.au ' + u + '@' + d + ' '//--> Abstract This article reviews ethically relevant history of tuberculosis and recent developments regarding extensively drug resistant tuberculosis (XDR-TB). It argues that tuberculosis is one of the most important neglected topics in bioethics. With an emphasis on XDR-TB, it examines a range of the more challenging ethical issues as…Read more
  •  17
    Dual‐Use Research
    In Hugh LaFollette (ed.), The International Encyclopedia of Ethics, Wiley-blackwell. 2013.
  •  17
    Centre for Applied Philosophy and Public Ethics (CAPPE), Menzies Centre for Health Policy, The Australian National University, LPO Box 8260, ANU Canberra ACT 2601, Australia. Tel.: +61 (0)2 6125 4355; Mobile: +61 (0)431 124 286; Fax: +61 (0)2 6125 6579; Email: michael.selgelid{at}anu.edu.au ' + u + '@' + d + ' '//--> Abstract Thomas Pogge has proposed a supplement to the standard patent regime whereby innovating companies would be rewarded in proportion to the extent to which their innovations l…Read more
  •  23
    Gain-of-Function Research: Ethical Analysis
    Science and Engineering Ethics 22 (4): 923-964. 2016.
    Gain-of-function research involves experimentation that aims or is expected to increase the transmissibility and/or virulence of pathogens. Such research, when conducted by responsible scientists, usually aims to improve understanding of disease causing agents, their interaction with human hosts, and/or their potential to cause pandemics. The ultimate objective of such research is to better inform public health and preparedness efforts and/or development of medical countermeasures. Despite these…Read more
  •  20
    Whether or not MSF should provide unconditional treatment for lead poisoning in Nigeria partly depends on answers to empirical questions regarding what the overall consequences of such a practice are likely to be. Conditional provision of treatment may yield greater health benefits (especially if treatment resources are limited)
  •  6
    Book Review (review)
    South African Journal of Philosophy 21 (2): 144-146. 2002.
  •  16
    Burden of Proof in Bioethics
    with Julian J. Koplin
    Bioethics 29 (9): 597-603. 2015.
    A common strategy in bioethics is to posit a prima facie case in favour of one policy, and to then claim that the burden of proof falls on those with opposing views. If the burden of proof is not met, it is claimed, then the policy in question should be accepted. This article illustrates, and critically evaluates, examples of this strategy in debates about the sale of organs by living donors, human enhancement, and the precautionary principle. We highlight general problems with this style of arg…Read more
  •  37
    Module four: Standards of care and clinical trials
    Developing World Bioethics 5 (1). 2005.
    ABSTRACTThis module examines ethical debates about the level of care that should be provided to human research participants. Particular attention is placed on the question of what should be considered an ethically acceptable control arm. You will also learn what relevant international and domestic regulatory documents say about standards of care